- Home
- RLAY vs OCFC Comparison
RLAY vs OCFC Comparison
Compare RLAY & OCFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- OCFC
- Stock Information
- Founded
- RLAY 2015
- OCFC 1902
- Country
- RLAY United States
- OCFC United States
- Employees
- RLAY N/A
- OCFC N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- OCFC Major Banks
- Sector
- RLAY Health Care
- OCFC Finance
- Exchange
- RLAY Nasdaq
- OCFC Nasdaq
- Market Cap
- RLAY 803.4M
- OCFC 944.6M
- IPO Year
- RLAY 2020
- OCFC 1996
- Fundamental
- Price
- RLAY $5.48
- OCFC $17.85
- Analyst Decision
- RLAY Strong Buy
- OCFC Buy
- Analyst Count
- RLAY 8
- OCFC 4
- Target Price
- RLAY $17.25
- OCFC $21.25
- AVG Volume (30 Days)
- RLAY 1.6M
- OCFC 266.3K
- Earning Date
- RLAY 11-05-2025
- OCFC 10-22-2025
- Dividend Yield
- RLAY N/A
- OCFC 4.48%
- EPS Growth
- RLAY N/A
- OCFC N/A
- EPS
- RLAY N/A
- OCFC 1.41
- Revenue
- RLAY $8,355,000.00
- OCFC $376,075,000.00
- Revenue This Year
- RLAY $27.33
- OCFC N/A
- Revenue Next Year
- RLAY $8.87
- OCFC $12.44
- P/E Ratio
- RLAY N/A
- OCFC $12.67
- Revenue Growth
- RLAY N/A
- OCFC 0.00
- 52 Week Low
- RLAY $1.78
- OCFC $14.29
- 52 Week High
- RLAY $7.07
- OCFC $21.87
- Technical
- Relative Strength Index (RSI)
- RLAY 75.63
- OCFC 49.91
- Support Level
- RLAY $5.17
- OCFC $17.16
- Resistance Level
- RLAY $5.42
- OCFC $18.42
- Average True Range (ATR)
- RLAY 0.29
- OCFC 0.44
- MACD
- RLAY 0.08
- OCFC -0.06
- Stochastic Oscillator
- RLAY 95.97
- OCFC 49.29
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.